ACB
ACB
NASDAQ · Pharmaceuticals

Aurora Cannabis Inc

$3.87
+0.02 (+0.52%)
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 6 60%
Hold 4 40%
Sell 0 0%
Price Target
Analyst Price Target +422.5% upside
Low Target $15.45
Average Target $20.22
High Target $24.58
Current Price $3.87
Current
$3.87
Target
$20.22
$15.45 $20.22 avg $24.58
Scenario Analysis
Bear Case
$15.45
299.2%
Low target
Base Case
$20.22
+422.5%
Avg target
Bull Case
$24.58
+535.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$9.33
-58.5% from high
52-Week Low
$3.59
+7.8% from low
Target vs 52W High
$20.22
+116.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%